Headlands Technologies’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.57K	Buy	+1,254	New	+$4.57K	﹤0.01%	1071
2024 Q3	–	Sell	-208	Closed	-$212	–	1162
2024 Q2	$212	Sell	208 -2,529	-92%	-$2.58K	﹤0.01%	1079
2024 Q1	$5.01K	Buy	+2,737	New	+$5.01K	﹤0.01%	1102